Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov ID: NCT06394973

Public ClinicalTrials.gov record NCT06394973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety Assessment of T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%) Versus Rhopressa® Ophthalmic Solution (Preserved Netarsudil 0.02%) in Patients With Open-angle Glaucoma or Ocular Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose is to compare the ocular hypotensive efficacy and safety of two concentrations of T4090 (Kinezodianone R HCl 0.2% and 0.3%) ophthalmic solution with Rhopressa® ophthalmic solution

Study identification

NCT ID
NCT06394973
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Laboratoires Thea
Industry
Enrollment
161 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 5, 2024 (Actual)
Primary completion
Nov 21, 2024 (Actual)
Completion
Nov 21, 2024 (Actual)
Last update posted
Jan 2, 2026

2024

United States locations

U.S. sites
24
U.S. states
10
U.S. cities
22
Facility City State ZIP Site status
Arizona Advanced Eye Research Institute Glendale Arizona 85306 —
Global Research Management, Inc. Glendale California 91204 —
United Medical Research Institute Inglewood California 90301 —
Eye Research Foundation Newport Beach California 92663 —
Visionary Research Institute Newport Beach California 92663 —
North Bay Eye Associates Petaluma California 94954 —
Sacramento Eye Consultants, A Medical Corporation Sacramento California 95815 —
Wolstan and Goldberg Eye Associates Torrance California 90505 —
Segal Drug Trials, Inc Delray Beach Florida 33484 —
East Coast Institute for Research, LLC Jacksonville Florida 32256 —
Shettle Eye Research, Inc. Largo Florida 33773 —
Mild Florida Eye Center Mt. Dora Florida 32757 —
Coastal Research Associates, LLC Roswell Georgia 30076 —
Seidenberg Protzko Eye Associates Havre de Grace Maryland 21078 —
Alterman, Modi and Wolter Ophthalmic Surgeons Poughkeepsie New York 12603 —
James D. Branch, MD Winston-Salem North Carolina 27101 —
Total Eye Care, PA Memphis Tennessee 38119 —
Keystone Research Austin Texas 78731 —
Glaucoma Associates of Texas Dallas Texas 75231 —
Houston Eye Associates Houston Texas 53719 —
Houston Eye Associates Houston Texas 77008 —
DCT-Shah Research, LLC sba Discovery Clinical Trials Mission Texas 78572 —
Emerson Clinical Research Institute Falls Church Virginia 22046 —
Piedmont Eye Center Lynchburg Virginia 24502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06394973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06394973 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →